Skip to main content
. Author manuscript; available in PMC: 2017 Jun 2.
Published in final edited form as: J Clin Oncol. 2004 Mar 15;22(6):1078–1086. doi: 10.1200/JCO.2004.07.048

Table 3.

Severe Toxicities Within the Two Treatment Arms

PSC-MEC
(n = 68)
MEC
(n = 69)
Toxicity (grade 3/4) No. of Patients % No. of Patients %
Neurologic 16 24 11 16

Hepatic 41 60* 26 38*

Lethal 11 16   7 10

Abbreviations: PSC-MEC, valspodar plus mitoxantrone, etoposide, and cytarabine; MEC, mitoxantrone, etoposide, and cytarabine.

*

Predominantly transient hyperbilirubinemia.